Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects
Clinical trial NCT02251223 · COMPLETED
Trial details
- NCT number
- NCT02251223
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-02-01
- Primary completion
- 2002-02-01
- Enrollment
- 208
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.